Biotron Limited

ASX (AUD): Biotron Limited (BIT)

Last Price

0.005

Today's Change

-0.004 (44.44%)

Day's Change

0.005 - 0.008

Trading Volume

33,705,292

Profile
BIT

Exchange: 

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO: 

Full Time Employees: 

IPO Date: 

CIK: 

ISIN: 

CUSIP: 

Beta: 

Last Dividend: 

Dcf Diff: 

Dcf: 

Description

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.

Address

http://www.biotron.com.au

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment